Pilot Study on Evaluating the Geroprotective Effect of Metformin
Status:
RECRUITING
Trial end date:
2028-07-31
Target enrollment:
Participant gender:
Summary
The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.
Phase:
PHASE2
Details
Lead Sponsor:
Xuanwu Hospital, Beijing
Collaborators:
Beijing Institute of Genomics, Chinese Academy of Sciences Institute of Zoology, Chinese Academy of Sciences Merck Serono Co., Ltd., China